Aller au contenu
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Langue
Tous les champs
Titre
Auteur
Sujet
Cote
ISBN/ISSN
Tag
Rechercher
Recherche avancée
IN PATIENTS WITH ANKYLOSING SP...
Citer
Envoyer par SMS
Envoyer par courriel
Imprimer
Exporter les notices
Exporter vers RefWorks
Exporter vers EndNoteWeb
Exporter vers EndNote
Permalien
IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES
Détails bibliographiques
Auteurs principaux:
Wordsworth, P
,
Rudwaleit, M
,
Claudepierre, P
,
Loza, E
,
Olivieri, I
,
Wong, R
,
Oezer, U
,
Kary, S
,
Kupper, H
Format:
Conference item
Publié:
2009
Exemplaires
Description
Documents similaires
Affichage MARC
Documents similaires
Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
par: Rudwaleit, M, et autres
Publié: (2008)
Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS)
par: Rudwaleit, M, et autres
Publié: (2008)
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.
par: Rudwaleit, M, et autres
Publié: (2009)
Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody
par: Wordsworth, P, et autres
Publié: (2008)
Efficacy of adalimumab in uveitis in patients with ankylosing spondylitis
par: Shandor Fedorovich Erdes
Publié: (2012-03-01)